386 related articles for article (PubMed ID: 26666336)
41. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection.
Khalili M; Lim JW; Bass N; Ascher NL; Roberts JP; Terrault NA
Liver Transpl; 2004 Mar; 10(3):349-55. PubMed ID: 15004760
[TBL] [Abstract][Full Text] [Related]
42. Divergent trajectories of lean
Qazi-Arisar FA; Uchila R; Chen C; Yang C; Chen SY; Karnam RS; Azhie A; Xu W; Galvin Z; Selzner N; Lilly L; Bhat M
World J Gastroenterol; 2022 Jul; 28(26):3218-3231. PubMed ID: 36051335
[TBL] [Abstract][Full Text] [Related]
43. Reduced impact of renal failure on the outcome of patients with alcoholic liver disease undergoing liver transplantation.
Cheong J; Galanko JA; Arora S; Cabezas J; Ndugga NJ; Lucey MR; Hayashi PH; Barritt AS; Bataller R
Liver Int; 2017 Feb; 37(2):290-298. PubMed ID: 27258535
[TBL] [Abstract][Full Text] [Related]
44. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
[TBL] [Abstract][Full Text] [Related]
45. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis.
Vallin M; Guillaud O; Boillot O; Hervieu V; Scoazec JY; Dumortier J
Liver Transpl; 2014 Sep; 20(9):1064-71. PubMed ID: 24961607
[TBL] [Abstract][Full Text] [Related]
46. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
[TBL] [Abstract][Full Text] [Related]
47. Non-alcoholic steatohepatitis and liver transplantation.
Gitto S; Vukotic R; Vitale G; Pirillo M; Villa E; Andreone P
Dig Liver Dis; 2016 Jun; 48(6):587-91. PubMed ID: 27038703
[TBL] [Abstract][Full Text] [Related]
48. The Impact of Preexisting and Post-transplant Diabetes Mellitus on Outcomes Following Liver Transplantation.
Aravinthan AD; Fateen W; Doyle AC; Venkatachalapathy SV; Issachar A; Galvin Z; Sapisochin G; Cattral MS; Ghanekar A; McGilvray ID; Selzner M; Grant DR; Selzner N; Lilly LB; Renner EL; Bhat M
Transplantation; 2019 Dec; 103(12):2523-2530. PubMed ID: 30985734
[TBL] [Abstract][Full Text] [Related]
49. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
Ong J; Younossi ZM; Reddy V; Price LL; Gramlich T; Mayes J; Boparai N
Liver Transpl; 2001 Sep; 7(9):797-801. PubMed ID: 11552214
[TBL] [Abstract][Full Text] [Related]
50. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation.
Carter D; Dieterich DT; Chang C
Clin Liver Dis; 2018 Feb; 22(1):213-227. PubMed ID: 29128058
[TBL] [Abstract][Full Text] [Related]
51. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
[TBL] [Abstract][Full Text] [Related]
52. Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times.
Gitto S; Marra F; De Maria N; Bihl F; Villa E; Andreone P; Burra P
Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):173-178. PubMed ID: 30791778
[TBL] [Abstract][Full Text] [Related]
53. Post-liver transplantation diabetes mellitus: an association with hepatitis C.
AlDosary AA; Ramji AS; Elliott TG; Sirrs SM; Thompson DM; Erb SR; Steinbrecher UP; Yoshida EM
Liver Transpl; 2002 Apr; 8(4):356-61. PubMed ID: 11965580
[TBL] [Abstract][Full Text] [Related]
54. Liver transplantation and non-alcoholic fatty liver disease.
Zezos P; Renner EL
World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
[TBL] [Abstract][Full Text] [Related]
55. The association of hepatitis C virus infection and post-liver transplant diabetes: data from 17 000 HCV-infected transplant recipients.
Younossi Z; Stepanova M; Saab S; Trimble G; Mishra A; Henry L
Aliment Pharmacol Ther; 2015 Jan; 41(2):209-17. PubMed ID: 25413020
[TBL] [Abstract][Full Text] [Related]
56. Prevalence of type 2 diabetes mellitus in Brazilian liver transplant candidates: negative association with HCV status.
Parolin MB; Zaina FE; Araújo MV; Kupka E; Coelho JC
Transplant Proc; 2004 Nov; 36(9):2774-5. PubMed ID: 15621146
[TBL] [Abstract][Full Text] [Related]
57. Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge.
Steggerda JA; Mahendraraj K; Todo T; Noureddin M
World J Gastroenterol; 2020 Jul; 26(28):4018-4035. PubMed ID: 32821068
[TBL] [Abstract][Full Text] [Related]
58. The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study.
Hamid O; Eltelbany A; Mohammed A; Alsabbagh Alchirazi K; Trakroo S; Asaad I
Ann Hepatol; 2022; 27(5):100727. PubMed ID: 35700934
[TBL] [Abstract][Full Text] [Related]
59. Recurrence of graft steatosis after liver transplantation for cryptogenic cirrhosis in recently commenced liver transplant program.
Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage CA; Gunetilleke B; de Silva HJ
Indian J Gastroenterol; 2016 May; 35(3):222-4. PubMed ID: 27142096
[TBL] [Abstract][Full Text] [Related]
60. The impact of gender and NASH on chronic kidney disease before and after liver transplantation.
Fussner LA; Charlton MR; Heimbach JK; Fan C; Dierkhising R; Coss E; Watt KD
Liver Int; 2014 Sep; 34(8):1259-66. PubMed ID: 24262002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
